Select basic information for advanced search
| Free word |
|---|
ナタリズマブの安全性と有効性:製造販売後調査4年目の中間解析結果
About SAIDA TAKAHIKO
About 関西多発性硬化症(MS)セ
About SAIDA TAKAHIKO
About 京都保健会 京都民医連中央病院
About YOKOYAMA KAZUMASA
About 順天堂大 医 神経学
About SATO RYUSUKE
About バイオジェン・ジャパン
About MAKIOKA TAIKI
About バイオジェン・ジャパン
About IIZUKA YUKIHIKO
About バイオジェン・ジャパン
About SUGIYAMA NAMI
About バイオジェン・ジャパン
About MATSUDA NAOTO
About バイオジェン・ジャパン
About TORII SHIN'ICHI
About バイオジェン・ジャパン
Material：
About 日本神経学会学術大会プログラム・抄録集
Volume： 60th Page： 434 Publication year： 2019
JST Material Number： L4990A Document type： Proceedings
Article type： 会議録記事 Country of issue： Japan (JPN) Language： JAPANESE (JA)
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
About human
Semi thesaurus term：
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
About natalizumab
Please login to MyJ-GLOBAL to see full information. You also need to select "Display abstract, etc. of medical articles" in your MyJ-GLOBAL account page in order to see abstracts, etc. of medical articles.
Category name(code) classified by JST.
About Drug therapy(=pharmacotherapy)for nervous system diseases
About Treatment for immunologic diseases,allergic diseases.
About Clinical application of immunotherapeutic agents and blood preparations
Keywords automatically extracted from the title.
About ナタリズマブ
About 安全性
About 有効性
About 製造販売後調査
About 中間解析
Return to Previous Page
